| abstract |
The present application relates to the use of an Enterobacteriaceae-specific inhibitor in the manufacture of a medicament for preventing, alleviating and/or treating distal injury associated with gastrointestinal ischemia-reperfusion in a subject. The present application also relates to the use of Enterobacteriaceae for the screening of drugs for preventing, ameliorating and/or treating distal injury associated with gastrointestinal ischemia-reperfusion in a subject. The present application also relates to pharmaceutical compositions comprising said Enterobacteriaceae-specific inhibitors and methods of preventing, ameliorating and/or treating distal injury associated with gastrointestinal ischemia-reperfusion in a subject. |